Arima T, Mizuno T, Ohshima Y, Kitamura Y, Segawa T, Nomura Y
Department of Pharmacology, Faculty of Pharmaceutical Sciences, Hokkaido University, Sapporo, Japan.
Neurosci Res. 1997 Mar;27(3):229-33. doi: 10.1016/s0168-0102(97)01156-5.
A novel pathway of 5-hydroxytryptamine (5-HT)-induced cGMP formation, which does not require Ca2+ and is distinct from the 5-HT, receptor-mediated pathway, is reported to exist in NG108-15 cells. Although the possible involvement of undefined 5-HT receptors and membrane-bound guanylyl cyclase is suggested. the mechanism is not clarified in detail in this Ca2+ -independent cGMP formation. In the present study, we investigated the activation mechanism of guanylyl cyclase activity. 5-HT-induced Ca2+ -independent cGMP formation was not observed in the cell membrane preparation. In intact cells, the 5-HT-induced Ca2+ -independent cGMP formation was inhibited by 2-(4-carboxyphenyl)-4,4,5,5-tetramethylimidazolin-1-oxyl 3-oxide (carboxyPTIO), a nitric oxide (NO)-specific trapper, and by 3,7-bis(dimethylamino)-phenothiazinium chloride (methylene blue), a cytosolic guanylyl cyclase-specific inhibitor, suggesting the involvement of NO and cytosolic guanylyl cyclase. Ca2+ -independent cGMP formation was not inhibited by 1,2-bis(o-aminophenoxy)-ethane-N,N,N',N'-tetraacetic acid tetra(acetoxymethyl)ester (BAPTA-AM), N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide (W-7), and various arginine-derivative nitric oxide synthase (NOS) inhibitors. Our findings suggest that 5-HT stimulation results in the generation of NO followed by cGMP formation in an NOS-independent manner in NG108-15 cells.
据报道,在NG108 - 15细胞中存在一种新型的5 - 羟色胺(5 - HT)诱导的环磷酸鸟苷(cGMP)形成途径,该途径不需要Ca2 + ,且与5 - HT受体介导的途径不同。尽管提示可能涉及未明确的5 - HT受体和膜结合鸟苷酸环化酶,但在这种不依赖Ca2 + 的cGMP形成过程中,其机制尚未得到详细阐明。在本研究中,我们研究了鸟苷酸环化酶活性的激活机制。在细胞膜制剂中未观察到5 - HT诱导的不依赖Ca2 + 的cGMP形成。在完整细胞中,5 - HT诱导的不依赖Ca2 + 的cGMP形成受到2 -(4 - 羧基苯基)- 4,4,5,5 - 四甲基咪唑啉 - 1 - 氧基3 - 氧化物(羧基PTIO,一种一氧化氮(NO)特异性捕获剂)和3,7 - 双(二甲基氨基)- 吩噻嗪氯化铵(亚甲蓝,一种胞质鸟苷酸环化酶特异性抑制剂)的抑制,提示NO和胞质鸟苷酸环化酶的参与。不依赖Ca2 + 的cGMP形成不受1,2 - 双(邻氨基苯氧基)乙烷 - N,N,N',N' - 四乙酸四(乙酰氧甲基)酯(BAPTA - AM)、N -(6 - 氨基己基)- 5 - 氯 - 1 - 萘磺酰胺(W - 7)以及各种精氨酸衍生的一氧化氮合酶(NOS)抑制剂的抑制。我们的研究结果表明,在NG108 - 15细胞中,5 - HT刺激导致以不依赖NOS的方式产生NO,随后形成cGMP。